Charles Gasparovic

Charles Gasparovic

Auto-generated profile, based on publicly available information

Charles Gasparovic

Department of Neurosciences, University of New Mexico School of Medicine, Albuquerque 87131, USA

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2006 in Magnetic Resonance in Medicine
Verified
Journal Article
Closed access
PDF file
CGCharles Gasparovic
Charles Gasparovic
TSTao Song
Tao Song
DDDeidre Devier
Deidre Devier
HBH. Jeremy Bockholt
H. Jeremy Bockholt
ACArvind Caprihan
Arvind Caprihan
LMLeslie A. Morrison
Leslie A. Morrison

21 February 2020 in NMR in Biomedicine
Verified
Journal Article
Closed access
PDF file
JNJamie Near
Jamie Near
AHAshley D. Harris
Ashley D. Harris
CJChristoph Juchem
Christoph Juchem
RKRoland Kreis
Roland Kreis
MMMałgorzata Marjańska
Małgorzata Marjańska
CGCharles Gasparovic
Charles Gasparovic

1 October 2009 in Journal of Neurotrauma
Verified
Journal Article
Closed access
CGCharles Gasparovic
Charles Gasparovic
RYRonald Yeo
Ronald Yeo
MMMaggie Mannell
Maggie Mannell
JLJosef Ling
Josef Ling
RERobert Elgie
Robert Elgie
AMAndrew R. Mayer
Andrew R. Mayer
Single-voxel proton magnetic resonance imaging (1H-MRS) and proton MR spectroscopic imaging (1H-MRSI) were used to compare brain metabolite levels in semi-acute mild traumatic brain injury (mTBI) patients (n = 10) and matched healthy controls (n = 9). The 1H-MRS voxel was positioned in the splenium, a region known to be susceptible to axonal injury in TBI, and a single 1H-MRSI slice was positioned above the lateral ventricles. To increase sensitivity to the glutamate (Glu) and the combined glutamate-glutamine (Glx) signal, an inter-pulse echo time shown to emphasize the major Glu signals was used along with an analysis method that reduces partial volume errors by using water as a concentration standard. Our preliminary findings indicate significantly lower levels of gray matter Glx and higher levels of white matter creatine-phosphocreatine (Cr) in mTBI subjects relative to healthy controls. Furthermore, Cr levels were predictive of executive function and emotional distress in the combined groups. These results suggest that perturbations in Cr, a critical component of the brain's energy metabolism, and Glu, the brain's major neurotransmitter, may occur following mTBI. Moreover, the different pattern of results for gray and white matter suggests tissue-specific metabolic responses to mTBI.

17 August 2020 in NMR in Biomedicine
Verified
Journal Article
Open access
PDF file
RKRoland Kreis
Roland Kreis
VBVincent Boer
Vincent Boer
ICIn‐Young Choi
In‐Young Choi
CCCristina Cudalbu
Cristina Cudalbu
RGRobin A. de Graaf
Robin A. de Graaf
Wolfgang BognerWolfgang Bogner
Wolfgang Bogner
With a 40‐year history of use for in vivo studies, the terminology used to describe the methodology and results of magnetic resonance spectroscopy (MRS) has grown substantially and is not consistent in many aspects. Given the platform offered by this special issue on advanced MRS methodology, the authors decided to describe many of the implicated terms, to pinpoint differences in their meanings and to suggest specific uses or definitions. This work covers terms used to describe all aspects of MRS, starting from the description of the MR signal and its theoretical basis to acquisition methods, processing and to quantification procedures, as well as terms involved in describing results, for example, those used with regard to aspects of quality, reproducibility or indications of error. The descriptions of the meanings of such terms emerge from the descriptions of the basic concepts involved in MRS methods and examinations. This paper also includes specific suggestions for future use of terms where multiple conventions have emerged or coexisted in the past.

1 March 2001 in Neuroscience Letters
Verified
Journal Article
Closed access
CGCharles Gasparovic
Charles Gasparovic
GRGary A. Rosenberg
Gary A. Rosenberg
JWJames A. Wallace
James A. Wallace
EEEduardo Y. Estrada
Eduardo Y. Estrada
KRKristianna Roberts
Kristianna Roberts
GGGlenn D. Graham
Glenn D. Graham

4 May 2018 in NMR in Biomedicine
Verified
Journal Article
Open access
PDF file
CGCharles Gasparovic
Charles Gasparovic
HCHongji Chen
Hongji Chen
PMPaul G. Mullins
Paul G. Mullins
Accurate measurement of brain metabolite concentrations with proton magnetic resonance spectroscopy (1H‐MRS) can be problematic because of large voxels with mixed tissue composition, requiring adjustment for differing relaxation rates in each tissue if absolute concentration estimates are desired. Adjusting for tissue‐specific metabolite signal relaxation, however, also requires a knowledge of the relative concentrations of the metabolite in gray (GM) and white (WM) matter, which are not known a priori. Expressions for the estimation of the molality and molarity of brain metabolites with 1H‐MRS are extended to account for tissue‐specific relaxation of the metabolite signals and examined under different assumptions with simulated and real data. Although the modified equations have two unknowns, and hence are unsolvable explicitly, they are nonetheless useful for the estimation of the effect of tissue‐specific metabolite relaxation rates on concentration estimates under a range of assumptions and experimental parameters using simulated and real data. In simulated data using reported GM and WM T1 and T2 times for N‐acetylaspartate (NAA) at 3 T and a hypothetical GM/WM NAA ratio, errors of 6.5–7.8% in concentrations resulted when TR = 1.5 s and TE = 0.144 s, but were reduced to less than 0.5% when TR = 6 s and TE = 0.006 s. In real data obtained at TR/TE = 1.5 s/0.04 s, the difference in the results (4%) was similar to that obtained with simulated data when assuming tissue‐specific relaxation times rather than GM–WM‐averaged times. Using the expressions introduced in this article, these results can be extrapolated to any metabolite or set of assumptions regarding tissue‐specific relaxation. Furthermore, although serving to bound the problem, this work underscores the challenge of correcting for relaxation effects, given that relaxation times are generally not known and impractical to measure in most studies. To minimize such effects, the data should be acquired with pulse sequence parameters that minimize the effect of signal relaxation.